NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

生物相似藥荷爾蒙的全球市場 (2020-2030年由於) :COVID-19的成長與變化

Biosimilar Hormones Global Market Report 2020-30: COVID-19 Growth and Change

出版商 The Business Research Company 商品編碼 977385
出版日期 按訂單生產 內容資訊 英文 200 Pages
商品交期: 2-10個工作天內
價格
生物相似藥荷爾蒙的全球市場 (2020-2030年由於) :COVID-19的成長與變化 Biosimilar Hormones Global Market Report 2020-30: COVID-19 Growth and Change
出版日期: 按訂單生產內容資訊: 英文 200 Pages
簡介

本報告提供全球生物相似藥荷爾蒙市場相關調查分析,市場概要,市場規模與預測,各市場區隔的市場分析,各地區、國家的市場分析,競爭情形等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 生物相似藥荷爾蒙市場特徵

第3章 生物相似藥荷爾蒙的市場規模、成長率

  • 全球市場的成果 (以金額為準)
    • 市場促進因素
    • 市場阻礙因素
  • 全球市場的預測 (以金額為準)
    • 市場促進因素
    • 市場阻礙因素

第4章 生物相似藥荷爾蒙市場區隔

  • 世界市場區隔:各類型,成果與預測 (以金額為準)
    • Teriparatide生物相似藥
    • 促濾泡素Alpha生物相似藥
    • 胰島素生物相似藥
    • 生長激素生物相似藥
    • 其他
  • 世界市場區隔:各應用領域,成果與預測 (以金額為準)
    • 研究&生物科技
    • 診斷
    • 生物催化劑
    • 治療
    • 其他

第5章 生物相似藥荷爾蒙市場:各地區、國家分析

  • 全球市場的區分:各地區,成果與預測 (以金額為準)
  • 全球市場的區分:各國,成果與預測 (以金額為準)

第6章 亞太地區的生物相似藥荷爾蒙市場

  • 市場概要
  • 市場區隔:各類型,成果與預測 (以金額為準)

第7章 中國的生物相似藥荷爾蒙市場

第8章 印度的生物相似藥荷爾蒙市場

第9章 日本的生物相似藥荷爾蒙市場

第10章 澳洲的生物相似藥荷爾蒙市場

第11章 印尼的生物相似藥荷爾蒙市場

第12章 韓國的生物相似藥荷爾蒙市場

第13章 西歐的生物相似藥荷爾蒙市場

第14章 英國的生物相似藥荷爾蒙市場

第15章 德國的生物相似藥荷爾蒙市場

第16章 法國的生物相似藥荷爾蒙市場

第17章 東歐的生物相似藥荷爾蒙市場

第18章 俄羅斯的生物相似藥荷爾蒙市場

第19章 北美的生物相似藥荷爾蒙市場

第20章 美國的生物相似藥荷爾蒙市場

第21章 南美的生物相似藥荷爾蒙市場

第22章 巴西的生物相似藥荷爾蒙市場

第23章 中東的生物相似藥荷爾蒙市場

第24章 非洲的生物相似藥荷爾蒙市場

第25章 市場競爭情形和企業簡介

  • 競爭情形
  • 企業簡介
    • Teva Pharmaceutical
    • Gedeon Richter
    • Intas Pharmaceuticals
    • Biocon
    • Mylan

第26章 主要的收購與合併

第27章 市場趨勢與策略

第28章 未來展望和潛在性分析

第29章 附錄

目錄

“Biosimilar hormones Global Market Report 2020-30: COVID-19 Growth and Change ”from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global biosimilar hormones market.

This report focuses on biosimilar hormones market which is experiencing strong growth. The report gives a guide to the biosimilar hormones market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the biosimilar hormones? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Biosimilar hormones market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider biosimilar hormones market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The biosimilar hormones market section of the report gives context. It compares the biosimilar hormones market with other segments of the biosimilar hormones market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, biosimilar hormones indicators comparison.

Scope

Markets Covered:

  • 1) By Type: Teriparatide Biosimilars; Follitropin Alfa Biosimilars; Insulin Biosimilars; Somatropin Biosimilars; Others 2) By Application: Research & biotechnology; Diagnostics; Biocatalysts; Therapeutics; Others
  • Companies Mentioned: Teva Pharmaceutical; Gedeon Richter; Intas Pharmaceuticals; Biocon; Mylan
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series:: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations:: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Biosimilar Hormones Market Characteristics

3. Biosimilar Hormones Market Size And Growth

  • 3.1. Global Biosimilar Hormones Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Biosimilar Hormones Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Biosimilar Hormones Market Segmentation

  • 4.1. Global Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Teriparatide Biosimilars
  • Follitropin Alfa Biosimilars
  • Insulin Biosimilars
  • Somatropin Biosimilars
  • Others
  • 4.2. Global Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Research & biotechnology
  • Diagnostics
  • Biocatalysts
  • Therapeutics
  • Others

5. Biosimilar Hormones Market Regional And Country Analysis

  • 5.1. Global Biosimilar Hormones Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Biosimilar Hormones Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Biosimilar Hormones Market

  • 6.1. Asia-Pacific Biosimilar Hormones Market Overview
  • 6.2. Asia-Pacific Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Biosimilar Hormones Market

  • 7.1. China Biosimilar Hormones Market Overview
  • 7.2. China Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Biosimilar Hormones Market

  • 8.1. India Biosimilar Hormones Market Overview
  • 8.2. India Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Biosimilar Hormones Market

  • 9.1. Japan Biosimilar Hormones Market Overview
  • 9.2. Japan Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Biosimilar Hormones Market

  • 10.1. Australia Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Biosimilar Hormones Market

  • 11.1. Indonesia Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Biosimilar Hormones Market

  • 12.1. South Korea Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Biosimilar Hormones Market

  • 13.1. Western Europe Biosimilar Hormones Market Overview
  • 13.2. Western Europe Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Biosimilar Hormones Market

  • 14.1. UK Biosimilar Hormones Market Overview
  • 14.2. UK Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Biosimilar Hormones Market

  • 15.1. Germany Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Biosimilar Hormones Market

  • 16.3. France Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Biosimilar Hormones Market

  • 17.1. Eastern Europe Biosimilar Hormones Market Overview
  • 17.2. Eastern Europe Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Biosimilar Hormones Market

  • 18.1. Russia Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Biosimilar Hormones Market

  • 19.1. North America Biosimilar Hormones Market Overview
  • 19.2. North America Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Biosimilar Hormones Market

  • 20.1. USA Biosimilar Hormones Market Overview
  • 20.2. USA Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Biosimilar Hormones Market

  • 21.1. South America Biosimilar Hormones Market Overview
  • 21.2. South America Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Biosimilar Hormones Market

  • 22.1. Brazil Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Biosimilar Hormones Market

  • 23.1. Middle East Biosimilar Hormones Market Overview
  • 23.2. Middle East Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Biosimilar Hormones Market

  • 24.1. Africa Biosimilar Hormones Market Overview
  • 24.2. Africa Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Biosimilar Hormones Market Competitive Landscape And Company Profiles

  • 25.1. Biosimilar Hormones Market Competitive Landscape
  • 25.2. Biosimilar Hormones Market Company Profiles
    • 25.2.1. Teva Pharmaceutical
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Gedeon Richter
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Intas Pharmaceuticals
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Biocon
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Mylan
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Biosimilar Hormones Market

27. Biosimilar Hormones Market Trends And Strategies

28. Biosimilar Hormones Market Future Outlook and Potential Analysis

29. Appendix

  • 29.1. Abbreviations
  • 29.2. Currencies
  • 29.3. Research Inquiries
  • 29.4. The Business Research Company
  • 29.5. Copyright And Disclaimer